Recursion Pharmaceuticals (RXRX) News Today $5.22 -0.06 (-1.14%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$5.22 +0.00 (+0.10%) As of 07/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RXRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period D.A. Davidson & CO. Raises Stock Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)July 11, 2025 | marketbeat.comMorgan Stanley Assumes Coverage of Recursion Pharmaceuticals (RXRX) Stock with an Equal Weight RatingJuly 10, 2025 | msn.comRecursion Pharmaceuticals (RXRX) Rallies 8.7% on HypophosphatasiaJuly 9, 2025 | insidermonkey.comRecursion Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RXRX)July 9, 2025 | marketbeat.comRallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25MJuly 9, 2025 | finance.yahoo.com10 Under-the-Radar Tech Stocks With Incredible Growth PotentialJuly 9, 2025 | fool.comRecursion Pharmaceuticals (RXRX) Drops on Profit-TakingJuly 8, 2025 | insidermonkey.comRecursion Pharmaceuticals: Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for HypophosphatasiaJuly 8, 2025 | finanznachrichten.deRecursion Pharmaceuticals Stock Gains on Plans to Buy Drug-Development Interest from RallybioJuly 8, 2025 | marketwatch.comRecursion Pharmaceuticals stock soars after acquiring HPP treatment from RallybioJuly 8, 2025 | in.investing.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading 6.7% Higher - Should You Buy?July 8, 2025 | marketbeat.comRecursion Pharmaceuticals' (RXRX) Buy Rating Reaffirmed at Needham & Company LLCJuly 8, 2025 | marketbeat.com10 Stocks Crash Hard Alongside Wall StreetJuly 8, 2025 | insidermonkey.comRecursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for HypophosphatasiaJuly 8, 2025 | finance.yahoo.comWhat's Happening With RXRX Stock?July 8, 2025 | forbes.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 6.2% - Here's WhyJuly 7, 2025 | marketbeat.comWhat Analysts Are Saying About Recursion Pharmaceuticals StockJuly 3, 2025 | benzinga.comRecursion Pharmaceuticals (NASDAQ:RXRX) Earns Equal Weight Rating from Analysts at Morgan StanleyJuly 3, 2025 | marketbeat.comKinnevik AB publ Has $71.07 Million Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)July 3, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 3.2% - Time to Buy?July 2, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Has $44.86 Million Stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)July 2, 2025 | marketbeat.comRecursion Pharmaceuticals, Inc. (RXRX) - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 4.5% - Should You Buy?June 30, 2025 | marketbeat.comMIT & Recursion Unveil Boltz-2, Accelerates Drug Discovery 1000x, Rivals Physics-Based AccuracyJune 30, 2025 | msn.comRecursion Pharmaceuticals Inc Class A RXRX - MorningstarJune 28, 2025 | morningstar.comMWhy This Wildcard Stock Could Be a Future StarJune 28, 2025 | msn.comRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 1.2% - Time to Sell?June 26, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down - Here's What HappenedJune 26, 2025 | marketbeat.comMorgan Stanley Trims Recursion (RXRX) Price Target, Maintains Equal Weight RatingJune 26, 2025 | msn.comRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 3.9% - What's Next?June 25, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 7.3% - Time to Buy?June 24, 2025 | marketbeat.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Average Rating of "Hold" from AnalystsJune 24, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 1.1% - What's Next?June 23, 2025 | marketbeat.comRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Position Boosted by SG Americas Securities LLCJune 20, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Shares Up 5.6% - Here's What HappenedJune 19, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Up 6.5% - Time to Buy?June 18, 2025 | marketbeat.comExpert Outlook: Recursion Pharmaceuticals Through The Eyes Of 4 AnalystsJune 17, 2025 | benzinga.comMorgan Stanley Lowers Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $5.00June 16, 2025 | marketbeat.comIs This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?June 16, 2025 | fool.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 2.2% - Here's WhyJune 13, 2025 | marketbeat.comLeerink Partnrs Has Positive Estimate for RXRX Q2 EarningsJune 13, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 2.4% - Should You Sell?June 12, 2025 | marketbeat.comRecursion Pharmaceuticals (NASDAQ:RXRX) Trading 4% Higher - Should You Buy?June 11, 2025 | marketbeat.comRecursion to lay off 20% of workforce amid biotech funding woesJune 11, 2025 | msn.comRecursion: Lack Of Near-Term Catalysts Leaves The Stock VulnerableJune 11, 2025 | seekingalpha.comRecursion Pharmaceuticals Stock Is Up 10% Today: What's Happening?June 10, 2025 | benzinga.comRecursion Pharmaceuticals: Recent Readouts Disappointing, Future Readouts RiskyJune 10, 2025 | seekingalpha.comRecursion Pharma to reduce workforce by 20%June 10, 2025 | msn.comRecursion Pharmaceuticals (RXRX) Jumps 31% On Next-Gen AIJune 10, 2025 | msn.comWhy Recursion Pharmaceuticals Was Bouncing Higher on TuesdayJune 10, 2025 | fool.com Get Recursion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos RXRX Media Mentions By Week RXRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RXRX News Sentiment▼0.720.97▲Average Medical News Sentiment RXRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RXRX Articles This Week▼810▲RXRX Articles Average Week Get Recursion Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Blueprint Medicines News Today Roivant Sciences News Today Elanco Animal Health News Today Legend Biotech News Today Regencell Bioscience News Today Revolution Medicines News Today Grifols News Today TG Therapeutics News Today Nuvalent News Today Lantheus News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RXRX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXRX Stock Alerts